{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:56:53Z","timestamp":1787497013429,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,5,3]],"date-time":"2014-05-03T00:00:00Z","timestamp":1399075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00535-014-0960-0","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T11:33:10Z","timestamp":1399030390000},"page":"221-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem\/cilastatin as comparator"],"prefix":"10.1007","volume":"50","author":[{"name":"The BTI Therapy Research Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Tazuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Tsuyuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shomei","family":"Ryozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,3]]},"reference":[{"key":"960_CR1","unstructured":"Committee on Guidelines for the Management of Acute Cholangitis. Guidelines for the management of acute cholangitis\/cholecystitis. 1st ed. Tokyo: Igaku Tosho Shuppan; 2005."},{"key":"960_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00534-006-1150-0","volume":"14","author":"T Takada","year":"2007","unstructured":"Takada T, Kawarada Y, Nimura Y, et al. Background: Tokyo guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Surg. 2007;14:1\u201310.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"960_CR3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jinf.2004.11.007","volume":"51","author":"ZA Kanafani","year":"2005","unstructured":"Kanafani ZA, Khalife N, Kanj SS, et al. Antibiotic use in acute cholecystitis: practice patterns in the absence of evidence-based guidelines. J Infect. 2005;51:128\u201334.","journal-title":"J Infect"},{"key":"960_CR4","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/AAC.01083-07","volume":"52","author":"SH Choi","year":"2008","unstructured":"Choi SH, Lee JE, Park SJ, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC \u03b2-lactamase: implications for antibiotic use. Antimicrob Agents Chemother. 2008;52:995\u20131000.","journal-title":"Antimicrob Agents Chemother"},{"key":"960_CR5","first-page":"781","volume":"24","author":"S Tazuma","year":"2003","unstructured":"Tazuma S, Iwamoto K, Hyogo H, et al. Clinical experience of injectable ciprofloxacin (CIP) for biliary tract infection. J Biliary Tract Pancreas. 2003;24:781\u20135.","journal-title":"J Biliary Tract Pancreas"},{"key":"960_CR6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00535-009-0067-1","volume":"44","author":"S Tazuma","year":"2009","unstructured":"Tazuma S, Igarashi Y, Tsuyuguchi T, et al. Clinical efficacy of intravenous ciprofloxacin in patients with biliary tract infection: a randomized controlled trial with carbapenem as comparator. J Gastroenterol. 2009;44:781\u201392.","journal-title":"J Gastroenterol"},{"key":"960_CR7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1872-034X.2011.00783.x","volume":"41","author":"S Tazuma","year":"2011","unstructured":"Tazuma S, Igarashi Y, Inui K, et al. Clinical efficacy of i.v. doripenem, a new class of carbapenem, in patients with biliary tract infection: a multicenter trial. Hepatol Res. 2011;41:340\u20139.","journal-title":"Hepatol Res"},{"key":"960_CR8","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2165\/00003495-200868140-00007","volume":"68","author":"SJ Keam","year":"2008","unstructured":"Keam SJ. Doripenem; a review of its use in the treatment of bacterial infections. Drugs. 2008;68:2021\u201357.","journal-title":"Drugs"},{"key":"960_CR9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ja.2006.31","volume":"59","author":"S Sakyo","year":"2006","unstructured":"Sakyo S, Tomita H, Tanimoto K, et al. Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa. J Antibiot. 2006;59:220\u20138.","journal-title":"J Antibiot"},{"key":"960_CR10","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1128\/AAC.00464-08","volume":"52","author":"K Tanimoto","year":"2008","unstructured":"Tanimoto K, Tomita H, Fujimoto S, et al. Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation. Antimicrob Agents Chemother. 2008;52:3795\u2013800.","journal-title":"Antimicrob Agents Chemother"},{"key":"960_CR11","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jac\/35.6.855","volume":"35","author":"JJ Sung","year":"1995","unstructured":"Sung JJ, Suen R, Chung SC, et al. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: randomized, controlled clinical trial. J Antimicrob Chemother. 1995;35:855\u201364.","journal-title":"J Antimicrob Chemother"},{"key":"960_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000239575","volume":"43","author":"H Elkhaji","year":"1997","unstructured":"Elkhaji H, Kamili N, Linger L, et al. In vitro time-kill curves of cefepime and cefpirome combined with amikacin, gentamicin or ciprofloxacin against Klebsiella pneumoniae producing extended-spectrum beta-lactamase. Chemotherapy. 1997;43:245\u201353.","journal-title":"Chemotherapy"},{"key":"960_CR13","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1128\/AAC.42.8.2006","volume":"42","author":"Y Hirakata","year":"1998","unstructured":"Hirakata Y, Izumikawa K, Yamaguchi T, et al. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-\u03b2-lactamase gene blaIMP. Antimicrob agents Chemother. 1998;42:2006\u201311.","journal-title":"Antimicrob agents Chemother"},{"key":"960_CR14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"American Thoracic Society and Infection Diseases Society of America","year":"2005","unstructured":"American Thoracic Society and Infection Diseases Society of America. Guidelines for management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"key":"960_CR15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00534-012-0538-2","volume":"19","author":"T Tsuyuguchi","year":"2012","unstructured":"Tsuyuguchi T, Sugiyama H, Sakai Y, et al. Prognostic factors of acute cholangitis in cases managed using the Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012;19:557\u201365.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"960_CR16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s11695-008-9702-9","volume":"19","author":"A Csendes","year":"2009","unstructured":"Csendes A, Burgos AM, Roizblatt D, et al. Inflammatory response measured by body temperature, C-reactive protein and white blood cell count 1, 3, and 5 days after laparotomic or laparoscopic gastric bypass surgery. Obes Surg. 2009;19:890\u20133.","journal-title":"Obes Surg"},{"key":"960_CR17","first-page":"862","volume":"50","author":"N Shinagawa","year":"1997","unstructured":"Shinagawa N, Takeda S, Oohira S. Efficacy and safety of sulbactum\/cefoperazone for hepato-biliary infections. Jpn J Antibiot. 1997;50:862\u201370 (in Japanese with English abstract).","journal-title":"Jpn J Antibiot"},{"key":"960_CR18","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3748\/wjg.v10.i15.2281","volume":"10","author":"G Bassotti","year":"2004","unstructured":"Bassotti G, Chistolini F, Sietchiping-Nzepa F, et al. Empirical antibiotic treatment with piperacillin\u2013tazobactam in patients with microbiologically-documented biliary tract infections. World J Gastroenterol. 2004;10:2281\u20133.","journal-title":"World J Gastroenterol"},{"key":"960_CR19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/pgmj.2007.064683","volume":"83","author":"M Melzer","year":"2007","unstructured":"Melzer M, Toner R, Lacey S, et al. Biliary tract infection and bacteremia: presentation, structural abnormalities, causative organisms and clinical outcomes. Postgrad Med J. 2007;83:773\u20136.","journal-title":"Postgrad Med J"},{"key":"960_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00534-012-0562-2","volume":"20","author":"K Okamoto","year":"2013","unstructured":"Okamoto K, Takada T, Steven M, et al. TG13 management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20:55\u20139.","journal-title":"J Hepatobiliary Pancreat Sci"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-014-0960-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-014-0960-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-014-0960-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T22:25:34Z","timestamp":1565389534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-014-0960-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["960"],"URL":"https:\/\/doi.org\/10.1007\/s00535-014-0960-0","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,3]]}}}